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Abstract
Background: Peutz-Jeghers syndrome (PJS) is a rare disorder characterized by multiple gastrointestinal
hamartomatous polyps and mucocutaneous pigmentation. STK11 has been identified as a causative gene for this
disease.
Case presentation: Herein we report a Chinese Han kindred with PJS. Onset for the PJS signs in three of the patients
was rarely as early as at birth. We identified a novel heterozygous mutation (c.440_441delGT, p.Arg147Leufs*15) in the
gene STK11, causing a short frameshift followed by a deletion of 63% of the amino acids in the STK protein. This
mutation co-segregated with the PJS phenotype, and was absent in two hundred of unrelated ethnicity-matched
controls. The mutation led to expression decrease of unaffected STK11 protein in patients than in controls, as well in PJ
polyps than in circulating leucocytes from the patients. Phosphorylation levels of the downstream kinase AMPKα
altered according with the expression of STK11. These results indicated the possibility that haploinsufficiency and
epigenetic reduction of STK11 contributed to the pathogenesis of the disease.
Conclusion: This study identifies a novel mutation in the pathogenic gene STK11 leading to PJS.
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Background
Peutz-Jeghers syndrome (PJS) is a rare disorder character-
ized by multiple gastrointestinal hamartomatous polyps
and mucocutaneous pigmentation [1, 2]. The disorder ap-
pears without gender predominance and is discovered in
various ethnic groups, at an incidence estimated to range
from 1/50,000 to 1/200,000 [3]. Clinical diagnosis of PJS
can be made in a patient presenting one of the following
signs: no less than two histologically confirmed PJ polyps,
any number of PJ polyps with a family history of PJS, char-
acteristic mucocutaneous pigmentation with a family PJS
history, any number of PJ polyps associated with charac-
teristic mucocutaneous pigmentation [4]. Mucocutaneous
pigmented lesions usually occur at the lips, nostrils, peri-
anal area, or digits; PJ polyps usually occur in the
gastrointestinal tract, especially frequently in the small in-
testine, but have been also reported in extra-gastrointes-
tinal organs [5, 6]. The polyps can lead to complications
including alimentary canal obstruction, rectal prolapse, in-
tussusception and severe bleeding with secondary anemia
[7]. PJS increases the risk for various neoplasms, including
gastrointestinal and extra-gastrointestinal, benign and ma-
lignant [8–10]. The serine/threonine kinase 11 coding gene
(STK11) on chromosome 19p13.3 has been identified as a
pathogenic gene of PJS [11, 12]. PJS signs usually appear
within childhood or adolescent years [2, 3], and sometimes
can also be firstly diagnosed in newborns or adults [13–15].
Here we report a Chinese Han family with PJS caused by a
novel mutation (c.440_441delGT, p.Arg147Leufs*15) in the
STK11 gene.
Subjects
The Chinese Han kindred with PJS was from Zhanjiang,
Guangdong, China. Subjects in the kindred were
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diagnosed with or without PJS in Guangzhou Women
and Children’s Medical Center. The proband III-6 re-
ceived polyp surgery in the hospital mentioned above
and the other patients did in hospitals in Zhanjiang
(Fig. 1a). All of the unrelated Han controls were from
Guangdong, not younger than 40 years, and diagnosed
without PJS symptoms or family history in the First Af-
filiated Hospital of Guangdong Medical University.
Case presentation
Clinical presentation
Five patients distributed over three generations exhibited
an autosomal dominant mode (Fig. 1a). The age of onset
for mucocutaneous pigmentation was as early as at birth
in III6, II7, III4, and at two years in II3, (Table 1, Fig. 1b
and c). III6 was diagnosed with PJ polyps because of
blood in stool and received intestinal surgery at the first
year (Table 1). The PJ polyps relapsed and three hamar-
tomatous polyps were excised from cavity of the de-
scending colon at the age of 21 months (Fig. 1b). The
largest polyp was 2.7 × 1.8 cm, looked smooth on the
surface (Fig. 1b); its pedicle was 0.8 × 0.6 cm (data not
shown). As shown in hematoxylin-eosin stained tissue
slices, smooth muscle fibers from the muscularis mucosa
extended into the inter-cryptas (Fig. 1b). Focal
hemorrhage, necrosis and infiltration of a large number
of inflammatory cells were observed (Fig. 1b). The pro-
band’s father II3 exhibited pigmentation at both the lips
Fig. 1 a Pedigree of the family with PJS. Square indicates male, circle indicates female. Filled and unfilled symbols indicate affected and unaffected
individuals respectively. Slash indicates decedent. Arrow indicates the proband. b PJS signs the proband exhibited. Upleft, pigmentation at the lips;
upper right, colonoscopy, filled square indicates location of the polyps in the descending colon; bottom left, polyps excised from the descending
colon; bottom right, Representative hematoxylin-eosin-stained tissue slices of the largest polyp. c Sign of mucocutaneous pigmentation the proband’s
father exhibited
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and digits (Fig. 1c). His onset age was not defined but his
father said it was before 2 years old. He was diagnosed
with PJ polyps in the transverse colon at fifteen years
(Table 1). III4, the elder brother of the proband, was diag-
nosed with PJ polyps in the rectum at two years (Table 1).
The polyps extended out of the anus, as his parents de-
scribed. II7, the uncle of the proband, was diagnosed with
PJ polyps because of stomachache at sixteen years
(Table 1). A polyp as large as the fist was surgically excised
from the stomach, his families said. There is no deter-
mined information about the phenotypes of the grand-
mother I2 who died from neoplasm at forty. Her husband
and oldest son told us that she suffered from pigmentation
at the lips and digits, but the onset age was unknown. The
grandfatherI1 is now eighty-three years old, and the PJS




Antibody (ab79355) targeting site 332–336 in STK11
was purchased from Abcam (Cambridge, UK). AMPKα-
targeting antibaody (#2532) was purchased from Cell
Signaling Technology (Boston, USA). GAPDH-targeting
antibody (AF0006), phospho-AMPKα (Thr172)-targeting
antibody (AA393), horseradish peroxidase-conjugated
goat anti-rabbit secondary antibody (A0208), horseradish
peroxidase-conjugated goat anti-mouse secondary anti-
body (A0216) were all purchased from Beyotime (Nan-
tong, Jiangsu, China).
DNA preparation and sequencing of the STK11 gene
Peripheral blood was collected in EDTA anticoagulant
tubes. Genomic DNA was extracted from leukocytes
using the Wizard Genomic DNA Purification Kit (Pro-
mega, Madison, WI, USA) according to the manufac-
turer’s instructions. 30 ng of DNA was used as PCR
template to amplify the fragments of coding regions, 5′
and 3′ untranslated regions in STK11. Amplification
products were Sanger sequenced using the ABI Genetic
Analyzer (Applied Biosystems, Foster, CA, USA). The
sequences of primers used for PCR and sequencing were
listed in Additional file 1: Table S1.
Reverse transcription-polymerase chain reaction (RT-PCR)
assay
Total RNA was extracted from leukocytes using the TRI-
zol reagent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s protocol. RT-PCR assay was performed
using the OneStep RT-PCR Kit (QIAGEN, Dusseldorf,
Germany), according to the manufacturer’s protocol. RT-
PCR primers were listed in Additional file 1: Table S2.
Protein extraction and western blot assay
Leukocytes isolated from circulating blood were lysed
using RIPA lysis buffer (Beyotime, Nantong, Jiangsu,
China) on ice. The lysis product was centrifuged at
12,000 × g for 10 min at 4 °C. The supernatant was col-
lected for the following protein analysis. Tissue from the
PJ polyps was cut into pieces and homogenized in RIPA
lysis buffer (0.5 ml/100 mg tissue) for 10 min on ice.
Then centrifuged as described above. Protein concentra-
tion was determined using the BCA reagent (Beyotime,
Nantong, Jiangsu, China) according to the manufac-
turer’s instructions. The extracted proteins were isolated
by SDS-PAGE electrophoresis in SDS-PAGE electro-
phoresis buffer (Beyotime, Nantong, Jiangsu, China) with
90 V voltage. The isolated proteins in SDS-PAGE gel
were transfered onto polyvinylidene fluoride film in
Western Transfer Buffer (Beyotime, Nantong, Jiangsu,
China) with 200 mA current for 90 min. The polyvinyli-
dene fluoride film with proteins was further treated as
the following steps: incubated with 5% fat-free milk for
30 min and then with a primary antibody for 2 h at
room temperature, washed to eliminate unspecific bind-
ing of the antibody, incubated with an horseradish
peroxidase-conjugated secondary antibody for 1 h at
room temperature, washed to eliminate unspecific bind-
ing of secondary antibody, incubated with BeyoECL che-
miluminiscence reagent (Beyotime, Nantong, Jiangsu,
Table 1 Clinical features of the affected family members
ID II3 II7 III4 III6 I2
Gender male male male male female
Age (years) 46 38 13 4 Died of neoplasm at
forty
Age at onset for mucocutaneous
pigmentation (years)
earlier than 2 present at birth present at birth present at birth unknown











Age at first diagnosis of PJ polyps (years) 15 16 2 first year unknown
Age at the first resection of polyps (years) 16 16 2 first year unknown
Position of PJ polyps transverse colon stomach rectum descending colon unknown
Chen et al. BMC Medical Genetics  (2017) 18:19 Page 3 of 6
China) according to the manufacturer’s instructions. Op-
tical density representing the protein amount was cap-
tured and analyzed using the Luminescent Imaging
Workstation (Tanon, Shanghai, China).
Hematoxylin-eosin staining of tissue slices
Paraffin-embedded polyp slices (5 μm of thick) were
treated as the following steps: immersed in xylene for
3 × 2 min, dehydrated using alcohol at gradient concen-
trations (100%, 95%, 80%, 70%) for 5 × 2 min respect-
ively, flushed with water for 3 min, incubated with
Harris hematoxylin solution for 3 min, flushed with
water for 3 min, incubated with 0.5% hydrochloric acid
for 10 s, flushed with water for 15 min, incubated with
alcohol (70%, 80% for 5 min respectively), incubated
with 95% eosin-alcohol solution for 30 s, incubated with
alcohol (95%, 100% for 5 min respectively), incubated
with xylene-alcohol mixture (1:1) for 5 min, incubated
with xylene for 5 min, sealed with neutral balsam and
covered with coverslip.
Results
We sequenced the exons, exon-intron boundaries, 5′ or
3′ untranslated region of the STK11 gene in all of the
family members. As a result, a heterozygous two-
nucleotide deletion in exon three (c.440_441delGT) co-
Fig. 2 A novel mutation (c.440_441delGT, p.Arg147Leufs*15) in STK11 was discovered. a Representative graphs of DNA sequencing surrounding the
heterozygous mutation c.440_441delGT. b (Left) Schematics of the secondary structure or functional domains of the STK11 protein. NLS, Nuclear
localization signal, NRD or CRD, N- or C-terminal regulatory domain. (Right) Images of the results of allele-specific reverse-transcription-polymerase chain
reaction. WT, wild-type; MT, mutant. c Examination of the expression of unaffected STK11 protein, as well of the phosphorylation levels at threonine 172 in
AMPKα. Ctrl-L, circulating leukocytes from controls (II1,II4, II6, III5,I1, II8, III9, III10); PJS-L, circulating leukocytes from the four patients (II3, II7, III4, III6); PJS-P, PJ
polyps from III6. Unpaired 2-tailed Student’s t test was employed
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segregated with the PJS phenotypes (Fig. 2a). The muta-
tion caused a frameshift at site 147 and a premature ter-
mination of translation at site 161 (p.Arg147Leufs*15,
Fig. 2b). This mutation has not been reported in litera-
tures or recorded in mutation databases. DNA from two
hundred of unrelated ethnicity-matched normal individ-
uals were sequenced and as a result the mutation was
absent. Human STK11 protein comprises 433 residues,
including a kinase catalytic domain (residues 49–309),
N- and C-terminal regulatory domains, and a nuclear
localization signal near the N-terminal (Fig. 2b). The
frameshift led to a deletion of 57% of the catalytic do-
main and the whole C-terminal regulatory domain. We
further studied the affection to mRNA using allele-
specific reverse-transcription-polymerase chain reaction
assay. As shown in Fig. 2b, all of the patients had a
mutation-specific amplicon along with a wild-type-
specific one, while two control family members just had
the latter.
To study the functional affection of the mutation, we
investigated STK11 protein expression in circulating leu-
kocytes, using an antibody that targets residues 332–336
in STK11 and consequently reacts with the wild-type
but not affected STK11. As a result, expression of the
wild-type STK11 in controls was significantly higher
than that in the patients (p = 0.0019, Fig. 2c), suggesting
that the disease might result from STK11 haploinsuffi-
ciency. Interestingly, we found the wild-type STK11
expressed less in the three PJ polyps from patient III-6
than in circulating leukocytes from the four patients (p
= 0.0252, Fig. 2c), suggesting that epigenetic reduction of
STK11 expression might be a second contribution to
polyps formation. AMPKα has been reported to be
phosphorylated at threonine 172 by STK11 [16, 17].
Here we also observed that the phosphorylation levels
of AMPKα paralleled with the levels of STK11 ex-
pression (Fig. 2c).
PJS onset in most reported patients was within child-
hood or adolescent years and it was reported that the
median time to onset for gastrointestinal symptoms was
13 years of age [2, 15]. In this study, the age of onset for
pigmentation in three of the patients was as early as at
birth, not firstly but relatively rarely reported. The onset
heterogeneity of PJS in this family was not confirmed.
There is no determined information about the PJS onset
in two of the patients. But it can’t exclude the possibility
that the disease onset in the two patients was also as
early as at birth. The heterogeneity in polyps location in
spite of the same mutation remains to be studied.
As a positive regulation, STK11 is released and shut-
tles from nucleus to cytoplasm, and interacts with
STRADα/β and MO25α/β to stabilize the kinase activity
[16, 18]. The entire kinase catalytic domain and amino
acids 319–343 in STK11 are necessary for binding to
STRAD [18]. So it is self-evident that the mutant identi-
fied here is unable to associate with the STRADα/β-
MO25α/β complex. Other interacting partners of STK11
have been successively identified and the indispensable
motifs in STK11 for interacting with some of them have
not yet been determined [19]. So we can’t exclude the
possibility that dominant negative effect is a third mo-
lecular mechanism by which the mutation results in PJS,
if the inactive mutant occupies the partners.
Discussion
There are hundreds of mutations in the STK11 gene re-
ported to cause PJS. Here we identified a novel mutation
which leads to a truncated STK11 protein, functionly
causes inherited, even early-onset (remained to be fur-
ther confirmed) PJS. Epigenetic expression reduction
might be also one of the pathogenic mechanisms caused
by the mutation. This study further expanded the muta-
tion spectrum of PJS.
Conclusion
In conclusion, in this study we identified a novel hetero-
zygous mutation (c.440_441delGT, p.Arg147Leufs*15) in
the STK11 gene causing the inherited PJS in this family.
Haploinsufficiency and epigenetic expression reduction
of STK11 might contribute to the pathogenesis of the
disease.
Additional file
Additional file 1: Table S1. Sequences of the primers for PCR and
sequencing of the STK11 gene. Table S2.. Sequences of the RT-PCR
primers. (DOC 31 kb)
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